Cardionovum

Be up
to date.

Latest press release

Cardionovum® announces First Procedure in Hyper II International Clinical Trial.

CARDIONOVUM® today announced the enrollment of the first patient in the International Hyper II Clinical Study

Learn more >>

CARDIONOVUM® announces the first Signature RCT patient enrollment

On June 8th, in Sankt Gertrauden hospital in Berlin, Germany, the first Signature RCT patient has been enrolled

Learn more >>

CARDIONOVUM announces completion of patients enrolment in XLIMIT Trial

Trial designed to evaluate non inferiority of XLIMUS DES vs SYNERGY EES in terms of reendothelialization assessed with OCT in patients undergoing percutaneous coronary intervention

Learn more >>

Two-year outcomes with the LEGFLOW DCB: primary patency maintained in real world patients.

Marc Bosiers (St. Blasius Hospital, Dendermonde, Belgium) will give an update at LINC today on the results of the REFLOW1 study, which investigated the efficacy of the LEGFLOW® drug-coated balloon (DCB) in TASC C and D femoropopliteal lesions.

Learn more >>

APERTO DCB “superior” for AV fistulae lesions in new RCT.

Professor Dr Qizhuang Jin (Peking University First Hospital Nephrology Department, China) spoke to LINC Today about the recently published results of the first randomised controlled trial (RCT) comparing the APERTO® drug-coated balloon (DCB) with high pressure angioplasty balloon in the treatment of arteriovenous fistulae (AVF) lesions.

Learn more >>

APERTO DCB “promising” for central venous stenosis in haemodialysis patients.

In a Q&A with LINC Today, Michael Lichtenberg, angiologist at Klinikum Hochsauerland GmbH, Arnsberg, Germany, discussed the APERTO® OTW (over-the-wire) drug coated balloon (DCB) currently being trialled in haemodialysis patients with central venous stenosis (CVS) in a bid to improve patency of arteriovenous fistulas (AVFs).

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum at Linc 2022

Cardionovum invites you to participate in a scientific session:

  • Pr. Matteo Tozzi will disclose the results of his study:
    Paclitaxel blood concentration after peripheral DCB PTA evaluated by HPLC

    Tuesday 7th June at 14,25h
    Speakers Corner

     

You are welcome to visit us at booth #10

Date: June 06, 2022–June 10, 2022

Location: Trade Fair Leipzig, Hall 2 - Seehausener Allee 1 - 04356 Leipzig, Germany

Learn more >>

Cardionovum at EuroPCR 2022

Cardionovum invites you to participate in 3 scientific sessions:

  • XLIMT trial with Dr. Luca Testa.
    Primary end point presentation.

    Available online:
    Poster Lab section
    17th-20th May

  • Restore SVD randomized trial with Dr. Changdong Guan.
    4 Year follow up presentation.

    On demand section:
    17th-20th May

  • HYPER study with Dr. Alfonso Ielasi.
    Primary end point presentation.

    In person presentation:
    Thursday 19th, 10:30- 12:00h Room Maillot

You are welcome to visit us at booth F6

Date: May 17, 2022–May 21, 2022

Location: France Palais des congrès, Paris

Learn more >>

Cardionovum GmbH at: "A glimpse into the future"

Cardionovum GmbH participates in:
The 1st symposium of interventional & clinical cardiology "A glimpse into the future". Dominican Society of Cardiology.

You are cordially invited to visit our booth.

Location: Convention Center, UTESA, Santiago, Dominican Republic

Download the program here (PDF)

Date: Jan 28, 2022–Jan 30, 2022

go top